ICG- Liver Test Versus New Biomarkers as Prognostic Markers in Critically Ill Patients (Greenpep)

University of Zurich (UZH)

Status: Completed

Conditions: Critically Ill

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT01126554

CIM_02 (Other Identifier)

CIM_MB 002

Details and patient eligibility

About

Comparison of ICG liver testing with copeptin and SAPS II score as prognostic markers in critically ill patients.

Full description

Comparison of different marker for length of stay in the ICU in critically ill patients.

Enrollment: 110 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients admitted to the ICU

Exclusion criteria

• Not able to understand German

Trial design

110 participants in 1 patient group

Critically ill patients